Serotipos no vacunales emergentes causantes de enfermedad neumocócica invasora en la era de la vacuna 7-valente-Reference-Cited by-同舟云学术

Serotipos no vacunales emergentes causantes de enfermedad neumocócica invasora en la era de la vacuna 7-valente

Published:2014-03 Issue:3 Volume:80 Page:173-180
ISSN:1695-4033
Container-title:Anales de Pediatría
language:es
Short-container-title:Anales de Pediatría

Author:

González Martínez F.,Navarro Gómez M.L.,Saavedra Lozano J.,Santos Sebastián M.M.,Rodríguez Fernández R.,González Sanchéz M.,Cercenado Mansilla E.,Hernández-Sampelayo Matos T.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference39 articles.

1. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group;Black;Pediatr Infect Dis J,2000

2. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: Group randomised trial;O’Brien;Lancet,2003

3. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine;Munoz-Almagro;Clin Infect Dis,2008

4. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: Impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines;Isaacman;Int J Infect Dis,2010

5. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar;Picazo;Clin Vaccine Immunol,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enfermedad neumocócica invasiva en niños menores de 60 meses, antes y después de la introducción de la vacuna conjugada 13-valente;Anales de Pediatría;2021-07

2. Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine;Anales de Pediatría (English Edition);2021-07

3. Epidemiology of pneumococcal diseases in Spain after the introduction of pneumococcal conjugate vaccines;Enfermedades Infecciosas y Microbiología Clínica;2021-03

4. Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines;PLOS ONE;2015-07-01

5. Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine;Jornal de Pediatria;2015-03